Next Article in Journal
Performance Analysis of D2D Communication with Retransmission Mechanism in Cellular Networks
Previous Article in Journal
A Part Consolidation Design Method for Additive Manufacturing based on Product Disassembly Complexity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Applied Sciences
Volume 10
Issue 3
10.3390/app10031099
applsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Analyzing the Association between Candida Prevalence, Species Specificity, and Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis— Candida and OSCC

by
Shankargouda Patil
Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia
Appl. Sci. 2020, 10(3), 1099; https://doi.org/10.3390/app10031099
Submission received: 14 January 2020 / Revised: 30 January 2020 / Accepted: 1 February 2020 / Published: 6 February 2020
(This article belongs to the Section Applied Dentistry and Oral Sciences)
Browse Figures
Review Reports Versions Notes

Abstract

:
The present review is a qualitative and quantitative analysis of the overall prevalence of Candida, and its species specificity in oral squamous cell carcinoma (OSCC). PubMed, Scopus, and Web of Science databases were searched using the keywords ‘Candida and oral squamous cell carcinoma’. Only case-control observational studies in the English language evaluating the prevalence and species specificity of Candida in OSCC were included. 297 articles were identified (PubMed-106, Scopus-148, Web of Science-43) using the keywords. After screening the titles and abstracts, 206 articles were removed as they were duplicates (118) or irrelevant to the topic (88). Full text of the remaining 91 articles was assessed using the inclusion criteria, based on which only seven articles were included in the systematic review. For the quantitative analysis, the odds ratio and confidence interval were assessed and a forest plot was generated. Based on the meta-analysis, there is an association between the total Candida, Candida albicans (CA) and OSCC, while the association with non-Candida albicans (NCA) is relatively weak. The number of studies included in the meta-analysis was relatively low (four to five). Further, at least one of the studies included in the meta-analysis for the association of CA., NCA and total Candida with OSCC had a Newcastle–Ottawa score below 7. Thus, although the results showed an association, the quality and quantity of the evidence may not be sufficient for conclusive inference.

1. Introduction

Oral squamous cell carcinoma (OSCC) is a multifactorial disease, with tobacco and alcohol being the most common independent risk factors [1,2,3,4,5]. Apart from these known risk factors, several factors (microbiome; lifestyle factors including obesity, diet, and occupation; environmental factors like air pollution, heavy metal exposure, and genetic susceptibility) have been implicated in the development of OSCC [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29], although their evidence of association is limited. Thus, such factors are termed potential risk factors. One such factor for OSCC is microorganisms. Studies have shown the presence of several oral microbes in OSCC patients [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]. Unlike external factors like tobacco and alcohol, the presence of oral microbes in an OSCC case could be a result of the microbe being a commensal or a secondary infection in the cancerous tissue. Thus, eliciting the role of microorganisms in OSCC would first require the establishment of a significantly higher association of the microbe in OSCC compared to healthy patients with normal oral mucosa. If a significant association is noted in OSCC, then the microbe in question can be assessed for the presence of carcinogenic properties. Among oral microbes, much importance has been given to human papillomavirus (HPV) types 16 and 18, due to their proven association with cervical and oropharyngeal cancer [30,31,32]. On the contrary, the role of HPV in OSCC remains inconclusive due to discrepancies in the results of individual studies [6]. Similar to HPV, microbes implicated in cancer in other anatomical locations including Helicobacter pylori in gastric cancer, have been assessed for its association with OSCC [33]. In most cases, the studies have been inconclusive, which is largely attributed to the differences in the sensitivity and specificity of the diagnostic modalities used to detect the microbes. In addition, if the oral microbe in question is present in a higher proportion as a commensal in the control (healthy individuals with normal oral mucosa) population, the results of the comparison between OSCC and the control often turn to insignificant or in few studies, even an inverse correlation has been recorded [20]. Due to these limitations, analyzing the association between oral microbes and OSCC has been largely inconclusive. One of the most commonly studied oral microbes in OSCC is Candida [16,17,18,19,34,35,36,37,38,39,40]. Candida albicans have shown to produce carcinogens including nitrosamines, which can activate proto-oncogenes triggering carcinomatous changes [41]. Candida is also capable of breaking down ethanol in to acetaldehyde, which in turn can cause adducts in protein and DNA [42,43,44,45]. These DNA adducts have shown to interfere with DNA replication resulting in point mutations, and aberrations of the chromosome [46]. Acetaldehyde has also shown to affect the cytosine methylation and DNA repair enzyme causing cell cycle aberrations which may culminate in tumor development [47]. In addition, acetaldehyde can increase the reactive oxygen species by binding with anti-oxidative peptide glutathione increasing the risk of DNA damage. The mitochondrial damages induced by the acetaldehyde have also shown to increase the reactive oxygen species, and key survival factors including NF-kb, which can in turn increase the risk of tumour development [48,49]. The acetaldehyde level considered to be carcinogenic is 4100 µM [43]. Among the Candida aspecies, Candida albicans (CA) and a few non-Candida albicans (NCA) including Candida parapsilosis and Candida tropicalis have shown to exceed this threshold level [41]. Despite multiple observational studies being published on the prevalence and species specificity of Candida in OSCC, the association of Candida with OSCC remains to be inconclusive, which again is due to the same limitations as suggested for H. pylori and HPV based studies. In addition, Candida pathogenesis and treatment sensitivity also vary significantly based on the species [50]. Thus, establishing a mere association between Candida and OSCC would not be sufficient. It would be necessary to identify both the Candida prevalence and species specificity in OSCC. Unlike Candida albicans (CA), which is regarded as a commensal, non-Candida albicans (NCA) such as C. tropicalis, C. glabrata, C. dubliniensis, C. krusei, and C. parapsiolosis have shown to exhibit inherent treatment resistance and are implicated in deteriorating the oral health [18,19,50]. Thus, NCA is designated as pathogenic microbes and their predominance in the oral cavity is considered as a sign of oral dysbiosis. A shift in the oral Candida flora towards NCA in OSCC could provide preliminary evidence of a potential pathogenic association between Candida and OSCC. Thus, the present systematic review assessed the published literature for studies investigating the total and species-specific Candida prevalence in OSCC. Based on the data obtained, the Candida prevalence and species specificity in OSCC were analyzed both qualitatively and quantitatively. The rationale for the meta-analysis was to estimate using the current published data if there is a significant difference in the Candida prevalence and species specificity between oral cancer tissue and the normal oral mucosa. A significantly higher Candida prevalence, and or a predominant NCA in OSCC compared to normal oral mucosa, would provide a preliminary evidence that Candida, especially the treatment-resistant NCA have an affinity towards OSCC, although it would not be possible to comment if the higher prevalence and/or NCA specificity is a result of the OSCC or the OSCC is a result of the higher prevalence and/or NCA specificity. The null hypothesis of the review was that there was no association between Candida and OSCC.

2. Materials and Methods

The systematic review strictly adhered to the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) protocol.

2.1. Inclusion Criteria

Observational case-control studies in the English language. Studies using individuals with clinically assessed normal oral mucosa (NOM) as the control group, and histopathologically confirmed cases of OSCC as the study group.

2.2. Exclusion Criteria

Studies other than case-control observation studies such as interventional studies. Reviews, individual case reports/series, abstract from conferences, commentaries, letters. Studies in a language other than English. Studies analyzing microorganisms other than Candida, and diseases other than OSCC.
The inclusion and exclusion criteria were framed r\to enable the identification of only the observational studies comparing the prevalence of Candida between OSCC and the normal oral mucosa using various diagnostic modalities.

2.3. Focused Question

Is there an association between Candida prevalence, species specificity, and OSCC?
The framework of the population (P), intervention (I), comparison (C), outcome (O), studies (S) were used for this focused question. P represents histopathologically confirmed cases of OSCC; I represents the diagnostic modality used to assess the presence of Candida; C represents clinically determined cases of NOM; O represents the Candida prevalence, species specificity in OSCC compared to the control group (NOM); S represents case-control observational studies.

2.4. Search Strategy

The SCOPUS, PubMed, and Web of Science databases were searched using the keywords “Candida and oral squamous cell carcinoma” until October 2019.

2.5. Studies Selection and Data Extraction

The review was conducted independently by two reviewers (SGP and ATR). The review consisted of two steps:
Step 1: The titles and abstracts of all identified articles were screened and the duplicates and irrelevant articles were excluded.
Step 2: The full text of the screened articles was assessed using the inclusion criteria.
Only those articles fulfilling the inclusion criteria and providing sufficient details to conduct the qualitative analysis were included.

2.6. Risk of Biased Assessment

The quality of the included studies was assessed using the Newcastle–Ottawa scale (NOS). Parameters including the comparability and selection outcome and exposure were considered to score the articles. The selection criteria had a maximum score of 4, the comparability criteria had a maximum score of 2, and the maximum score for the outcome, exposure criteria was 4. In total, a maximum of score 10 could be achieved by an article. Studies with scores higher than 7 were considered good.

2.7. Statistical Analysis

The Kappa coefficient was estimated to evaluate the inter-observer bias between the two reviewers (SGP and ATR). In addition to the systematic review, the data extracted was also subjected to meta-analysis. For the quantitative analysis, the confidence interval (CI) and odds ratio (OR) of the included studies were calculated. Only those studies with compatible data were subjected to quantitative analysis.

3. Results

3.1. Study Selection

Keywords ‘Candida and oral squamous cell carcinoma’, identified 297 (PubMed-106, Scopus-148, Web of Science-43) articles.
Step 1: Screening the titles and abstracts of the identified article revealed 118 duplicates and 88 irrelevant articles.
Step 2: The remaining 91 articles were subjected to full-text assessment using the selection criteria.
Only seven studies [34,35,36,37,38,39,40] satisfied the inclusion criteria and provided sufficient data for qualitative analysis. Figure 1 provides a summary of the search strategy employed in the systematic review. Values of 0.98 and 1 were found as the inter-reviewer Kappa coefficient values for the first and second steps of the review respectively. Data extracted from the included studies are summarized in Table 1.

3.2. Study Characteristics

Four studies [34,35,37,39] were from India, one [36] from Australia, one [38] from Argentina, and one [40] from Finland. The samples collected included oral rinse, saliva, and oral swab. The modalities used to identify the Candida prevalence and species specificity included Sabouraud dextrose agar (SDA), CHROMagar, germ tube test, API ID 32C, and Bichro-Dubli Fumouze latex agglutination tests, chlamydospore production in milk serum and in cornmeal broth +5% milk media/corn meal agar, colony morphology, sugar assimilation, fermentation tests, morphology in maize agar, growth at 42 °C, and real-time PCR (Polymerase chain reaction).

3.3. Newcastle–Ottawa Scale

Definition of the cases and control were provided by all seven [34,35,36,37,38,39,40] included studies. Four studies [36,37,38,40] matched the comparative groups for known confounding factors including age and gender. One study [35] matched for gender but not for the age. The two remaining studies [34,39] either did not provide any matching details or did not match the comparative groups. Matching for potential confounding factors was done in only one study [36] wherein the comparative groups were matched for the denture status. Three [34,35,39] of the seven included studies scored less than 7. The scores given to each of the included studies are summarized in Table 2.

3.4. Candida Prevalence in OSCC Compared to the NOM

The odds ratio and 95% confidence interval for the total Candida prevalence as estimated from each of the included studies are provided in Table 3. Based on the individual odds ratio, the overall ratio was estimated for total Candida prevalence in OSCC as 4.75 (95% confidence interval of 1.85–12.19) as shown in Table 4. The estimated overall ratio was used to generate the forest plots for Candida prevalence as shown in Figure 2. The data revealed a significant association between Candida and OSCC.

3.5. Candida Species Specificity in OSCC Compared to the NOM

The odds ratio and 95% confidence interval for the Candida species specificity as estimated from each of the included studies is provided in Table 3. Based on the individual odds ratio, the overall ratio was estimated for CA and NCA prevalence in OSCC as 2.75 (95% confidence interval of 1.13–6.71) and 1.95 (95% confidence interval of 0.73–5.20) respectively as shown in Table 4. The overall ratio of each species of the NCA was not calculated as the number of studies providing compatible data was limited (only one or two studies). Similar to Candida prevalence, the estimated overall ratio for CA and NCA was used to generate the forest plots as shown in Figure 3 and Figure 4 respectively. The data revealed a significant association between CA and OSCC, while the association between NCA and OSCC was not significant.

4. Discussion

Under physiological conditions, CA is considered as one of the most common Candida species in the oral cavity [51]. Thus, most studies on Candida have largely focused on CA. In a majority of these CA-based studies, the experimental model includes the isolation and characterization of the Candida from the oral cavity through salivary sampling, oral rinse, or an oral swab [34,35,36,37,38,39,40]. Estimating the prevalence of Candida and the species specificity for different population groups is a major research strategy employed in oral Candida-based studies. Despite being a commensal, CA is a well-established opportunistic infection, capable of inducing both local and systemic infections [51]. Thus, research on the prevalence and species specificity of Candida, including CA, has been extended to a wide range of disease entities, especially with immunodeficiency states such as HIV/AIDS, and transplant patients wherein the opportunistic nature of Candida have a higher risk of establishing an infection [52,53,54,55].
Although common anti-fungal agents have shown to effective against CA, their efficiency is relatively poor against the NCA due to their inherent treatment resistance and virulence properties [56,57]. A shift in the Candida flora from CA to NCA has been suggested as a sign of oral dysbiosis which could potentially increase the risk of local and systemic diseases, including cancer [18,19]. Several studies have evaluated the carcinogenic potential of Candida through epidemiological, in vitro, and in vivo studies [34,35,36,37,38,39,40,58,59,60,61,62,63,64]. Despite evidence of producing carcinogenic agents such as acetaldehyde [64], the evidence for a causal association between Candida and OSCC has been largely inconclusive. The lack of evidence is in turn attributed to the varying epidemiological data from individual studies [34,35,36,37,38,39,40]. To overcome the limitation of individual study differences, the present literature review was formulated to provide a comprehensive estimate of Candida prevalence and species specificity in OSCC through qualitative and quantitative analysis.
The present systematic review included seven case-control observational studies [34,35,36,37,38,39,40] wherein the control were individuals with normal oral mucosa and the cases were histopathologically confirmed OSCC. Although each study had other variable groups ranging from smokers, oral leukoplakia (OL), oral potentially malignant disorder (OPMD), oral lichen planus (OLP), the review focused primarily on the results of the Candida prevalence and species specificity in OSCC and the healthy controls. As mentioned earlier, the most common sampling techniques were oral swab, oral rinse, and saliva. Other than oral swab, the other sampling techniques could potentially include microbial colonies from different parts of the oral cavity and may not be a true representation of the lesional area. The most common diagnostic modality used was CHROMagar. Being a relatively economical modality compared to genotyping, the CHROMagar-based chromogenic differentiation is often the most desired system of Candida species differentiation. The subjectivity of the observers in determining the color of the colonies in CHROMagar often leads to inter-observer bias, which is its major limitation. Thus, many studies employ additional tests to confirm the findings of the CHROMagar. Some of the additional diagnostic modalities used in the studies included in the present review are the germ tube test, API ID 32C, Bichro-Dubli Fumouze -latex agglutination tests, chlamydospore production in milk serum and in cornmeal broth +5% milk media/corn meal agar, colony morphology, sugar assimilation, and fermentation tests, morphology in maize agar, growth at 42 °C, and real-time PCR. Among these given the relatively higher sensitivity and specificity, the use of molecular tools like PCR should be preferred in the future studies. Further use of more than one diagnostic modality (combining one of the preliminary tests like CHROMagar with a molecular tool) could in turn increase the reliability of the results.
Although all included studies had well-defined cases (histopathological confirmed OSCC) and control (clinically confirmed normal oral mucosa), there were several liabilities due to the lack of adequate matching between the comparison groups. Among the seven studies, only four studies [36,37,38,40] accounted for known confounders (age and gender), while one [35] matched only for gender and the remaining two studies [34,39] either did not provide any matching information or failed to match the groups. Additional matching for potential confounders was made in only one [36] of the included studies wherein the denture status was considered. The lack of adequate matching resulted in a relatively lower score for the included studies on the Newcastle–Ottawa scale (Table 2).
In order to quantitatively assess the association between Candida prevalence, species specificity in OSCC, the odds ratio at 95% confidence interval was calculated for each of the included studies (Table 3). Quantitative assessment was carried out only for those Candida species wherein the odds ratio was available from at least four studies. Forest plots were generated using the overall ratio (at 95% confidence interval) which in turn was calculated from the odds ratio obtained from the individual studies. Only total Candida, CA, and NCA association with OSCC had odds ratios from at least four studies and were assessed quantitatively. Based on the meta-analysis, a significant association was noted between both total Candida and OSCC. The result confirms the notion that Candida would be higher in the diseased state than the healthy controls. The clinical implication based on total Candida in OSCC is limited without knowing the species specificity. Similar to total Candida, even the CA showed a significant association with OSCC. Once again, CA being a commensal, its higher presence in OSCC just confirms its opportunistic nature. To establish a pathogenic aspect to Candida and OSCC, it was necessary to analyze the presence of the pathogenic Candida. Although NCA also showed an association with OSCC, the relationship was not significant. The nonsignificant association with NCA questions the notion that NCA could be a potential risk factor for OSCC. As mentioned earlier, since there were limited studies, it was not possible to analyze the association of OSCC with each NCA species individually. Thus, although overall NCA does not have a significant association with OSCC, it is unclear if there could be an NCA species-specific association with OSCC.

5. Conclusions

Based on the present systematic review and meta-analysis, OSCC has a significant association with Candida, and CA, while its association with NCA is not significant. A major parameter used to interpret the results of a qualitative and quantitative analysis would be the number and quality of the included studies. In the qualitative analysis, there were seven [34,35,36,37,38,39,40] studies included, with three [34,35,39] of them having scores below 7. In the quantitative analysis, there were only four to five studies included, wherein at least one of the included studies had a score less than seven. Thus, given the limited number of studies and their relatively lower Newcastle–Ottawa scores, the association noted in the present analysis must be inferred with caution. The main relevance of the present systematic review and meta-analysis was to assess the association of Candida and OSCC, and also to provide insight in to the quality and the quantity of studies estimating the same. As mentioned, there is a lack of both quality and quantity of studies analyzing the association between Candida and OSCC.
Future perspective: To improve the quality of the data, it is vital that future studies give sufficient importance to matching the comparison groups for both known and potential confounders. It is also of utmost importance that the studies are designed such that the examiners are blinded to the comparison groups.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risk in Humans. Tobacco Smoke and Involuntary Smoking; IARC Press: Lyon, France, 2004; Volume 83. [Google Scholar]
  2. Gandini, S.; Botteri, E.; Iodice, S.; Boniol, M.; Lowenfels, A.B.; Maisonneuve, P.; Boyle, P. Tobacco smoking and cancer: A meta-analysis. Int. J. Cancer 2008, 122, 155–164. [Google Scholar] [CrossRef] [PubMed]
  3. Znaor, A.; Brennan, P.; Gajalakshmi, V.; Mathew, A.; Shanta, V.; Varghese, C.; Boffetta, P. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int. J. Cancer 2003, 105, 681–686. [Google Scholar] [CrossRef] [PubMed]
  4. International Agency for Research on Cancer (IARC). Section 2.2. Cancer of the oral cavity and pharynx. In Alcohol Consumption and Ethylcarbamate; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Ed.; IARC Press: Lyon, France, 2010; Volume 96, pp. 237–329. [Google Scholar]
  5. Patil, S.; Arakeri, G.; Alamir, A.W.H.; Patil, S.; Awan, K.H.; Baeshen, H.; Raj, A.T.; Fonseca, F.P.; Brennan, P.A. Is Toombak a risk factor for oral leukoplakia and oral squamous cell carcinoma? A systematic review. J. Oral Pathol. Med. 2019. [Google Scholar] [CrossRef] [PubMed]
  6. Raj, A.T.; Patil, S.; Gupta, A.A.; Rajkumar, C.; Awan, K.H. Reviewing the role of human papillomavirus in oral cancer using the Bradford Hill criteria of causation. Dis. Mon. 2019, 65, 155–163. [Google Scholar] [CrossRef]
  7. Kerr, A.R. The oral microbiome and cancer. Am. Dent. Hyg. Assoc. 2015, 89 (Suppl. S1), 20–23. [Google Scholar]
  8. Schwabe, R.F.; Jobin, C. The microbiome and cancer. Nat. Rev. Cancer 2013, 13, 800. [Google Scholar] [CrossRef] [Green Version]
  9. Schmidt, B.L.; Kuczynski, J.; Bhattacharya, A.; Huey, B.; Corby, P.M.; Queiroz, E.L.; Nightingale, K.; Kerr, A.R.; De Lacure, M.D.; Veeramachaneni, R.; et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS ONE 2014, 9, e98741. [Google Scholar] [CrossRef]
  10. Pushalkar, S.; Ji, X.; Li, Y.; Estilo, C.; Yegnanarayana, R.; Singh, B.; Li, X.; Saxena, D. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol. 2012, 12, 144. [Google Scholar] [CrossRef] [Green Version]
  11. Nagy, K.N.; Sonkodi, I.; Szoke, I.; Nagy, E.; Newman, H.N. The microflora associated with human oral carcinomas. Oral Oncol. 1998, 34, 304–308. [Google Scholar] [CrossRef]
  12. Meurman, J.H.; Uittamo, J. Oral micro-organisms in the etiology of cancer. Acta Odontol. Scand. 2008, 66, 321–326. [Google Scholar] [CrossRef]
  13. Wang, L.; Ganly, I. The oral microbiome and oral cancer. Clin. Lab. Med. 2014, 34, 711–719. [Google Scholar] [CrossRef] [PubMed]
  14. García-Castillo, V.; Sanhueza, E.; McNerney, E.; Onate, S.A.; García, A. Microbiota dysbiosis: A new piece in the understanding of the carcinogenesis puzzle. J. Med. Microbiol. 2016, 65, 1347–1362. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Zhang, Z.; Yang, J.; Feng, Q.; Chen, B.; Li, M.; Liang, C.; Li, M.; Li, Z.; Xu, Q.; Zhang, L.; et al. Compositional and Functional Analysis of the Microbiome in Tissue and Saliva of Oral Squamous Cell Carcinoma. Front. Microbiol. 2019, 10, 1439. [Google Scholar] [CrossRef] [PubMed]
  16. Rodriguez-Archilla, A.; Alcaide-Salamanca, M.J. Candida species detection in potentially malignant and malignant disorders of the oral mucosa: A meta-analysis. J. Dent. Res. Rev. 2018, 5, 35–41. [Google Scholar] [CrossRef]
  17. Tamgadge, S.; Tamgadge, A.; Pillai, A.; Chande, M.; Acharya, S.; Kamat, N. Association of Candida sp. with the Degrees of Dysplasia and Oral Cancer: A Study by Calcofluor White under Fluorescent Microscopy. Iran. J. Pathol. 2017, 12, 348–355. [Google Scholar]
  18. Raj, A.T.; Patil, S.; Awan, K.H. Assessing the carcinogenic potential of non-Candida albicans in cancer therapy-induced oral mucositis. World J. Dent. 2018, 9, 79. [Google Scholar]
  19. Raj, A.T.; Patil, S.; Sujatha, G.; Seetharam, C.; Kader, N.A. Clinical significance of the floral shift in candidiasis. J. Contemp. Dent. Pract. 2018, 19, 1161–1162. [Google Scholar]
  20. Gupta, A.A.; Kheur, S.; Raj, A.T.; Mahajan, P. Association of Helicobacter pylori with oral potentially malignant disorders and oral squamous cell carcinoma—A systematic review and meta-analysis. Clin. Oral Investig. 2019, 24, 13–23. [Google Scholar] [CrossRef]
  21. Raj, A.T.; Patil, S.; Sarode, S.; Sarode, G.; Chandini, R. Evaluating the association between household air pollution and oral cancer. Oral Oncol. 2017, 75, 178–179. [Google Scholar] [CrossRef]
  22. Josyula, S.; Lin, J.; Xue, X.; Rothman, N.; Lan, Q.; Rohan, T.E.; Hosgood, H.D. Household air pollution and cancers other than lung: A meta-analysis. Environ. Health 2015, 14, 24. [Google Scholar] [CrossRef] [Green Version]
  23. Loomis, D.; Grosse, Y.; Lauby-Secretan, B.; El Ghissassi, F.; Bouvard, V.; Benbrahim-Tallaa, L.; Guha, N.; Baan, R.; Mattock, H.; Straif, K. The carcinogenicity of outdoor air pollution. Lancet Oncol. 2013, 14, 1262–1263. [Google Scholar] [CrossRef]
  24. Yuan, T.H.; Lian, I.B.; Tsai, K.Y.; Chang, T.K.; Chiang, C.T.; Su, C.C.; Hwang, Y.H. Possible association between nickel and chromium and oral cancer: A case-control study in central Taiwan. Sci. Total Environ. 2011, 409, 1046–1052. [Google Scholar] [CrossRef] [PubMed]
  25. Tsai, K.Y.; Su, C.C.; Chiang, C.T.; Tseng, Y.T.; Lian, I.B. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan. Cancer Epidemiol. 2017, 47, 118–124. [Google Scholar] [CrossRef]
  26. Kawakita, D.; Lee, Y.A.; Turati, F.; Parpinel, M.; Decarli, A.; Serraino, D.; Matsuo, K.; Olshan, A.F.; Zevallos, J.P.; Winn, D.M.; et al. Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium. Int. J. Cancer 2017, 141, 1811–1821. [Google Scholar] [CrossRef] [PubMed]
  27. Eural, M.; Katsura, F.; Olso, M.; Obata, A.; Nakano, K.; Masuyama, K.; Ishikawa, T. Frequency of HLA-A alleles in Japanese patients with head and neck cancer. Jpn. J. Clin. Oncol. 1999, 29, 535–540. [Google Scholar] [CrossRef] [Green Version]
  28. Dutta, A.; Saikia, N.; Phooka, J.; Baruah, M.N.; Baruah, S. Association of killer cell immunoglobulin-like receptor gene 2DL1and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma. Immunogenetics 2014, 66, 439–448. [Google Scholar] [CrossRef]
  29. Tsai, S.C.; Sheen, M.C.; Chen, B.H. Association between HLA-DQA1, HLA-DQB1 and oral cancer. Kaohsiung J. Med. Sci. 2011, 27, 441e445. [Google Scholar] [CrossRef] [Green Version]
  30. Berman, T.A.; Schiller, J.T. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer 2017, 123, 2219–2229. [Google Scholar] [CrossRef]
  31. LeConte, B.A.; Szaniszlo, P.; Fennewald, S.M.; Lou, D.I.; Qiu, S.; Chen, N.W.; Lee, J.H.; Resto, V.A. Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer. PLoS ONE 2018, 13, e0203403. [Google Scholar] [CrossRef] [Green Version]
  32. Rietbergen, M.M.; van Bokhoven, A.A.J.D.; Lissenberg-Witte, B.I.; Heideman, D.A.M.; Leemans, C.R.; Brakenhoff, R.H.; Bloemena, E. Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions. Int. J. Cancer 2018, 143, 283–288. [Google Scholar] [CrossRef]
  33. Meng, X.; Wang, Q.; He, C.; Chen, M.; Liu, J.; Liu, W.; Yuan, Y. An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma. J. Oral Pathol. Med. 2016, 45, 17–22. [Google Scholar] [CrossRef] [PubMed]
  34. Hulimane, S.; Maluvadi-Krishnappa, R.; Mulki, S.; Rai, H.; Dayakar, A.; Kabbinahalli, M. Speciation of Candida using CHROMagar in cases with oral epithelial dysplasia and squamous cell carcinoma. J. Clin. Exp. Dent. 2018, 10, e657–660. [Google Scholar] [CrossRef] [PubMed]
  35. Roy, S.K.; Astekar, M.; Sapra, G.; Chitlangia, R.K.; Raj, N. Evaluation of candidal species among individuals with oral potentially malignant disorders and oral squamous cell carcinoma. J. Oral Maxillofac. Pathol. 2019, 23, 302. [Google Scholar]
  36. Alnuaimi, A.D.; Wiesenfeld, D.; O’Brien-Simpson, N.M.; Reynolds, E.C.; McCullough, M.J. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: A matched case-control study. Oral Oncol. 2015, 51, 139–145. [Google Scholar] [CrossRef]
  37. Sankari, S.L.; Mahalakshmi, K. Oral candidal carriage among patients with oral squamous cell carcinoma: A case-control study. J. Orofac. Sci. 2019, 11, 55–58. [Google Scholar]
  38. Castillo, G.V.; de Blanc, S.L.; Sotomayor, C.E.; Azcurra, A.I. Study of virulence factor of Candida species in oral lesions and its association with potentially malignant and malignant lesions. Arch. Oral Biol. 2018, 91, 35–41. [Google Scholar] [CrossRef]
  39. Gupta, V.; Abhisheik, K.; Balasundari, S.; Devendra, N.K.; Shadab, K.; Anupama, M. Identification of Candida albicans using different culture media and its association in leukoplakia and oral squamous cell carcinoma. J. Oral Maxillofac. Pathol. 2019, 23, 28–35. [Google Scholar]
  40. Makinen, A.; Nawaz, A.; MAkitie, A.; Meurman, J.H. Role of non-albicans Candida and Candida albicans in oral squamous cell cancer Patients. J. Oral Maxillofac. Surg. 2018, 76, 2564–2571. [Google Scholar] [CrossRef] [Green Version]
  41. Ramirez-Garcia, A.; Rementeria, A.; Aguirre-Urizar, J.M.; Moragues, M.D.; Antoran, A.; Pellon, A.; Abad-Diaz-de-Cerio, A.; Hernando, F.L. Candida albicans and cancer: Can this yeast induce cancer development or progression? Crit. Rev. Microbiol. 2016, 42, 181–193. [Google Scholar]
  42. Mohd Bakri, M.; Mohd Hussaini, H.; Rachel Holmes, A.; David Cannon, R.; Mary Rich, A. Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma. J. Oral Microbiol. 2010, 2, 5780. [Google Scholar] [CrossRef]
  43. Nieminen, M.T.; Uittamo, J.; Salaspuro, M.; Rautemaa, R. Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol. 2009, 45, E245–E248. [Google Scholar] [CrossRef] [PubMed]
  44. Uittamo, J.; Siikala, E.; Kaihovaara, P.; Salaspuro, M.; Rautemaa, R. Chronic candidosis and oral cancer in APECED-patients: Production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans. Int. J. Cancer 2009, 124, 754–756. [Google Scholar] [CrossRef] [PubMed]
  45. Poschl, G.; Seitz, H.K. Alcohol and cancer. Alcohol Alcohol. 2004, 39, 155–165. [Google Scholar] [CrossRef] [Green Version]
  46. Seitz, H.K.; Stickel, F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 2007, 7, 599–612. [Google Scholar] [CrossRef] [PubMed]
  47. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans; World Health Organization International Agency for Research on Cancer, Ed.; IARC: Lyon, France, 1999; Volume 77, pp. 319–335. [Google Scholar]
  48. Manzo-Avalos, S.; Saavedra-Molina, A. Cellular and mitochondrial effects of alcohol consumption. Int. J. Environ. Res. Public Health 2010, 7, 4281–4304. [Google Scholar] [CrossRef] [Green Version]
  49. Seitz, H.K.; Homann, N. The role of acetaldehyde in alcoholassociated cancer of the gastrointestinal tract. Novartis Found. Symp. 2007, 285, 110–119. [Google Scholar]
  50. Whibley, N.; Gaffen, S.L. Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species. Cytokine 2015, 76, 42–52. [Google Scholar] [CrossRef] [Green Version]
  51. McManus, B.A.; Coleman, D.C. Molecular epidemiology, phylogeny and evolution of Candida albicans. Infect. Genet. Evol. 2014, 21, 166–178. [Google Scholar] [CrossRef] [Green Version]
  52. Katiraee, F.; Teifoori, F.; Soltani, M. Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran. Curr. Med. Mycol. 2015, 1, 11–16. [Google Scholar]
  53. Kirkpatrick, W.R.; Revankar, S.G.; McAtee, R.K. Detection of Candida dubliniensisin oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 1998, 36, 3007–3012. [Google Scholar] [CrossRef] [Green Version]
  54. Anwar, K.P.; Malik, A.; Subhan, K.H. Profile of candidiasis in HIV infected patients. Iran. J. Microbiol. 2012, 4, 204–209. [Google Scholar]
  55. Andes, D.R.; Safdar, N.; Baddley, J.W.; Alexander, B.; Brumble, L.; Freifeld, A.; Hadley, S.; Herwaldt, L.; Kauffman, C.; Lyon, G.M.; et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl. Infect. Dis. 2016, 18, 921–931. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Deorukhkar, S.C.; Saini, S.; Mathew, S. Non-albicans Candida Infection: An emerging threat. Interdiscip. Perspect. Infect. Dis. 2014, 2014, 7. [Google Scholar] [CrossRef] [Green Version]
  57. Silva, S.; Negri, M.; Henriques, M.; Oliveira, R.; Williams, D.W.; Azeredo, J. Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev. 2012, 36, 288–305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Kuriyama, T.; Williams, D.W.; Lewis, M.A. In vitro secreted aspartyl proteinase activity of Candida albicans isolated from oral diseases and healthy oral cavities. Oral Microbiol. Immunol. 2003, 18, 405–407. [Google Scholar] [CrossRef] [PubMed]
  59. Williams, D.W.; Bartie, K.L.; Potts, A.J.; Wilson, M.J.; Fardy, M.J.; Lewis, M.A. Strain persistence of invasive Candida albicans in chronic hyperplastic candidosis that underwent malignant change. Gerodontology 2001, 18, 73–78. [Google Scholar] [CrossRef] [PubMed]
  60. O’Grady, J.F.; Reade, P.C. Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis 1992, 13, 783–786. [Google Scholar] [CrossRef]
  61. Sanketh, D.S.; Patil, S.; Rao, R.S. Estimating the frequency of Candida in oral squamous cell carcinoma using Calcofluor White fluorescent stain. J. Investig. Clin. Dent. 2016, 7, 304–307. [Google Scholar] [CrossRef]
  62. Terayama, Y.; Matsuura, T.; Ozaki, K. Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation. PLoS ONE 2016, 11, e0159090. [Google Scholar] [CrossRef]
  63. Sanjaya, P.R.; Gokul, S.; Gururaj, P.B.; Raju, R. Candida in oral pre-cancer and oral cancer. Med. Hypotheses 2011, 77, 1125–1128. [Google Scholar] [CrossRef]
  64. Marttila, E.; Bowyer, P.; Sanglard, D.; Uittamo, J.; Kaihovaara, P.; Salaspuro, M.; Richardson, M.; Rautemaa, R. Fermentative 2-carbon metabolism produces carcinogenic levels of acetaldehyde in Candida albicans. Mol. Oral Microbiol. 2013, 28, 281–291. [Google Scholar] [CrossRef] [PubMed]
Applsci 10 01099 g001 550
Figure 1. Summary of the search strategy employed.
Figure 1. Summary of the search strategy employed.
Applsci 10 01099 g001
Applsci 10 01099 g002 550
Figure 2. Forest plot summarizing the results of the meta-analysis for Candida and OSCC.
Figure 2. Forest plot summarizing the results of the meta-analysis for Candida and OSCC.
Applsci 10 01099 g002
Applsci 10 01099 g003 550
Figure 3. Forest plot summarizing the results of the meta-analysis for CA and OSCC.
Figure 3. Forest plot summarizing the results of the meta-analysis for CA and OSCC.
Applsci 10 01099 g003
Applsci 10 01099 g004 550
Figure 4. Forest plot summarizing the results of the meta-analysis for NCA and OSCC.
Figure 4. Forest plot summarizing the results of the meta-analysis for NCA and OSCC.
Applsci 10 01099 g004
Table
Table 1. Summary of the data extracted from the studies included in the systematic review.
Table 1. Summary of the data extracted from the studies included in the systematic review.
First Authors Name/Year/Country [Reference Number]Comparison GroupsComparison Group MatchingSample CollectedModalities UsedResults of Candida, CA, and NCA
Hulimane/2018/India [34]OSCC-18OED-32NOM-50Details not providedOral swabSDA, CHROMagarCandida positive in OSCC-18, OED-32, NOM-2
CA positive in OSCC-10, OED-7, NOM-2
NCA positive in OSCC-8, OED-25, NOM-0
Additional information:C. tropicalis present in OSCC-6, OED-14, NOM-0; C. glabrata present in OSCC-2, OED-10, NOM-0.
Mixed colonies: CA and C. glabrada present in OSCC-0, OED-2, NOM-0.
Roy/2019/India [35]OSCC-40OPMD-30NOM-25Gender matched. Age was not matchedOral swabSDA, CHROMagarCandida positive in OSCC-31, OPMD-12, NOM-5
CA positive in OSCC-4, OPMD-7, NOM-4
NCA positive in OSCC-18, OPMD-5, NOM-1
Additional information:C. krusei present in OSCC-10, OPMD-5, NOM-1; C. glabrata present in OSCC-6, OED-10, NOM-0; C. topicalis present in OSCC-2, OPMD-0, NOM-0.
Mixed colonies: C. glabrata and C. krusei present in OSCC- 1, OPMD-0, NOM-0; C. tropicalis and C. krusei present in OSCC-3, OPMD-0, NOM-0; C. tropicalis and C. glabrata present in OSCC-1, OPMD-0, NOM-0; C. albicans and C. tropicalis present in OSCC-3, OPMD-0, NOM-0;C. krusei, C. glabrata with C. albicans present in OSCC-1, OPMD-0, NOM-0.
Alnuaimi/2015/Australia [36]OSCC-52NOM-104Age, gender, and denture status matchedOral rinseCHROMagar, Real-Time PCRCandida positive in OSCC-39, NOM-51
CA positive in OSCC-31, NOM-32
NCA positive in OSCC-8, NOM-19
Additional information:CA genotype A present in OSCC-27, NOM-15; CA genotype B present in OSCC-4, NOM-16; CA genotype C present in OSCC-0, NOM-1.
C. dubliniensis present in OSCC-3, NOM-3; C. glabrata present in OSCC-2, NOM-3; C. guilliermondii present in OSCC-2, NOM-0.
C. krusei present in OSCC-1, NOM-0; C. parapsilosis present in OSCC-0, NOM-9; C. tropicalis present in OSCC-0, NOM-3; C. lusitaniae present in OSCC-0, NOM-1.
Mixed colonies: C. albicans genotype A and C.glabrata present in two cases; C. albicans genotype A and C. parapsilosis present in two cases; C. albicans genotype B and C. tropicalis present in one case; C. albicans genotype A and C. lusitaniae present in one case; C. dubliniensis and C. parapsilosis present in one case. Overall OSCC-3, NOM—seven cases had mixed colonies. The article did not mention which mixed colonies were present in which comparative group.
Sankari/2019/India [37]OSCC-90NOM-170Age and gender matchedSalivaSDA, CHROMagar, germ tube tests, chlamydospore formation on cornmeal agar, sugar assimilation, and fermentation testsCandida positive in OSCC-63, NOM-34
CA positive in OSCC-26, NOM-19
NCA positive in OSCC-26, NOM-15
Mixed CA and NCA in OSCC-11, NOM-0
Additional information: Mixed colonies (CA and NCA) present in OSCC-11, NOM-0.
Castillo/2018/Argentina [38]OSCC-25Atypical OLP-11Chronic candidiasis-25NOM-15Age and gender matchedOral swabCHROMagar, colony morphology, sugar fermentation tests, germ tube test, morphology in maize agar, 42 °C growthCandida positive in OSCC-25, atypical OLP-11, chronic candidiasis-25, NOM-15
CA positive in OSCC-16, atypical OLP-6, chronic candidiasis-11, NOM-15
NCA positive in OSCC-9, atypical OLP-2, chronic candidiasis-7, NOM-0
Additional information:C. dubliniensis present in OSCC-2, NOM-0; C. glabrata present in OSCC-1, NOM-0; C. krusei present in OSCC-4, NOM-0; C. tropicalis present in OSCC-1, atypical lichen planus-2, chronic candidiasis-7, NOM-0.
Mixed colonies (CA and C.tropicalis) present in OSCC-0, atypical lichen planus-0, chronic candidiasis-2, NOM-0.
Gupta/2019/ India [39]OSCC-30OL-30NOM-20Details not providedSalivaSDA, germ tube test, chlamydospore production in milk serum and in cornmeal broth +5% milk mediaCandida positive in OSCC-14, OL-11, NOM-0CA positive in OSCC-11, OL-4, NOM-0
NCA positive in OSCC-3, OL-7, NOM-0
Additional information: The NCA identified was C. tropicalis. Details on mixed colonies were not provided.
Makinen/2018/Finland [40]OSCC-100NOM-75Age and gender-matchedSalivaCHROMagar
API ID 32C, and Bichro-Dubli Fumouze latex agglutination tests		Candida positive in OSCC-74, NOM-47
CA positive in OSCC-63, NOM-45
NCA positive in OSCC-17, NOM-11
Additional information:C. dubliniensis present in OSCC-6, NOM-4; C. tropicalis present in OSCC-3, NOM-0; C. glabrata present in OSCC-2, NOM-4; C. parapsilosis present in OSCC-2, NOM-1; Candida sake present in OSCC-2, NOM-0; C. krusei present in OSCC-1, NOM-0; C. guillermondii present in OSCC-1, NOM-1; C. kefyr present in OSCC-0, NOM-1.
Mixed colonies (2 species) present in seven cases. Mixed colonies (three species) present in one case. The article did not mention which mixed colonies were present in which comparative group.
Note: CA—Candida albicans; NCA—non-Candida albicans; OSCC—oral squamous cell carcinoma; NOM—normal oral mucosa; OL—oral leukoplakia; OLP—oral lichen planus; SDA—Sabouraud dextrose agar; OPMD—oral potentially malignant disorder.
Table
Table 2. Quality of the studies included in the systematic review as assessed by the Newcastle–Ottawa Scale.
Table 2. Quality of the studies included in the systematic review as assessed by the Newcastle–Ottawa Scale.
The First Author [Reference Number]SelectionComparabilityExposureTotal Score
Case DefinitionCase RepresentativenessControl SelectionControl DefinitionMatching Known Confounding FactorMatching Potential Confounding FactorSecure Patient RecordsInterviewer Blinded to Cases and ControlThe Similarity in the Case and Control AscertainmentNon-Response Rate
Hulimane [34]11110010106
Roy [35]11110010106
Alnuaimi [36]11111110107
Sankari [37]11111010107
Castillo [38]11111010107
Gupta [39]11110010106
Makinen [40]11111010107
Table
Table 3. Odds ratio and confidence interval calculated for Candida prevalence and species specificity from each study included in the systematic review.
Table 3. Odds ratio and confidence interval calculated for Candida prevalence and species specificity from each study included in the systematic review.
Author/Year/Country [Reference Number]Odds Ratio95% Confidence Interval
Candida and OSCC
Roy/2019/India [35]13.783.54–58.27
Alnuaimi/2015/Australia [36]3.121.42–7.09
Sankari/2019/India [37]9.334.99–17.54
Makinen/2015/Finland [40]1.700.84–3.41
CA and OSCC
Hulimane/2018/India [34]30.005.67–158.80
Roy/2019/India [35]0.580.10–3.51
Alnuaimi/2015/Australia [36]3.321.57–7.05
Sankari/2019/India [37]3.231.59–6.62
Makinen/2015/Finland [40]1.140.59–2.20
CA Genotype A
Alnuaimi/2015/Australia [36]6.412.77–14.96
CA Genotype B
Alnuaimi/2015/Australia [36]0.460.11–1.54
NCA and OSCC
Roy/2019/India [35]19.642.57–851.39
Alnuaimi/2015/Australia [36]0.780.27–2.04
Sankari/2019/India [37]3.661.73–7.93
Makinen/2015/Finland [40]1.190.49–3.02
C. dubliniensis and OSCC
Alnuaimi/2015/Australia [36]2.060.26–15.88
Makinen/2015/Finland [40]1.130.26–5.67
C. glabrata and OSCC
Alnuaimi/2015/Australia [36]1.350.11–12.13
Makinen/2015/Finland [40]0.360.03–2.62
C. krusei and OSCC
Roy/2019/India [35]8.000.99–361.35
C. parapsilosis and OSCC
Makinen/2015/Finland [40]1.510.08–90.28
C. guillermondii and OSCC
Makinen/2015/Finland [40]0.750.01–59.46
Table
Table 4. Random effect model-based assessment of overall ratio and 95% confidence intervals for Candida prevalence and species specificity from the studies included in the meta-analysis.
Table 4. Random effect model-based assessment of overall ratio and 95% confidence intervals for Candida prevalence and species specificity from the studies included in the meta-analysis.
Overall Ratio95% Confidence Interval
Candida and OSCC
4.751.85–12.19
CA and OSCC
2.751.13–6.71
NCA and OSCC
1.950.73–5.20
Note: The overall ratio was calculated only for those parameters which had meta-analysis compatible data from at least four studies.

Share and Cite

MDPI and ACS Style

Patil, S. Analyzing the Association between Candida Prevalence, Species Specificity, and Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis— Candida and OSCC. Appl. Sci. 2020, 10, 1099. https://doi.org/10.3390/app10031099

AMA Style

Patil S. Analyzing the Association between Candida Prevalence, Species Specificity, and Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis— Candida and OSCC. Applied Sciences. 2020; 10(3):1099. https://doi.org/10.3390/app10031099

Chicago/Turabian Style

Patil, Shankargouda. 2020. "Analyzing the Association between Candida Prevalence, Species Specificity, and Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis— Candida and OSCC" Applied Sciences 10, no. 3: 1099. https://doi.org/10.3390/app10031099

APA Style

Patil, S. (2020). Analyzing the Association between Candida Prevalence, Species Specificity, and Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis— Candida and OSCC. Applied Sciences, 10(3), 1099. https://doi.org/10.3390/app10031099

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop